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Background: By transdifferentiation, proximal tubular cells (PTC) have been considered as a
source of interstitial myofibroblasts. We examined the combined effect of transforming
growth factor-beta-1 (TGF-b1) stimulation and contact with type I collagen on PTC
transdifferentiation.
Methods: Human kidney-2 cells were grown on type I substratum with the concurrent
stimulation of TGF-b1.
Results: Following addition of TGF-b1, cells acquired an elongated fibroblastic appearance
and an increase in a-smooth muscle actin (a-SMA) expression, a myofibroblastic marker.
Upon addition of TGF-b1, E-cadherin expression, an epithelial marker, was reduced, while
cytokeratin expression, another epithelial marker, remained unaltered. Following removal
of TGF-b1, PTC regained an epithelial appearance and E-cadherin expression reverted to
the unstimulated level, suggesting incomplete and reversible transdifferentiation. Addition
of TGF-b1 to cells grown on type I collagen demonstrated a cooperatively increased a-SMA
expression and decreased E-cadherin and cytokeratin expressions, suggesting more com-
plete transdifferentiation. Co-stimulation of TGF-b1 and contact with type I collagen led to
a stable cell phenotype and persistently decreased E-cadherin, which was not reversed
upon removal of TGF-b1, indicating irreversible transdifferentiation. Addition of TGF-b1 or
type I collagen caused a 4-fold increase in migratory cell number as compared to the
control, whereas addition of both TGF-b1 and type I collagen led to an 11-fold increase.
Conclusions: TGF-b1 alone results in a reversible and incomplete transdifferentiation. The
combination of TGF-b1 and exposure to type I collagen leads to an irreversible and com-
plete PTC transdifferentiation.rology, Kidney Research Center, Chang Gung Memorial Hospital at Linkou, 5, Fusing St.,
81200 ext. 8181; fax: þ886 3 3282173.
tw (Y.-C. Tian).
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Scientific background of the subject
Proximal tubular cells (PTC) have been considered as a
source of interstitial myofibroblasts and transforming
growth factor-beta-1 (TGF-b1) is crucial to induce
phenotypic alterations of PTC to form fibroblastoid
morphology. But previous studies imply that there are
other factors required to cooperate with TGF-b1 to
complete terminal transdifferentiation.
What this study adds to the field
This study demonstrates that TGF-b1 alone causes
incomplete and reversible transdifferentiation. In
contrast, combination of TGF-b1 stimulation and contact
with type I collagen substratum cooperatively causes
complete and irreversible PTC transdifferentiation.It is now clear that progression of renal insufficiency is
closely correlated to the degree of renal interstitial fibrosis
[1,2]. Despite conflicting evidence arguing the origin of myo-
fibroblasts [3,4], it has been demonstrated that renal proximal
tubular cells (PTC) can contribute to progression of renal
fibrosis through a process called epithelial-mesenchymal
transition (EMT) or transdifferentiation, in which PTC exert a
phenotypic conversion to acquire characteristics of mesen-
chymal cells [5e7]. Early work of Strutz et al. suggested that
PTCmay express fibroblast-specificmarkers in vitro and in vivo
in a murine model of anti-tubular basement membrane and
anti-glomerular basement membrane model of nephritis [8].
Ng et al. have demonstrated de novo expression of a-smooth
muscle actin (a-SMA), a marker of myofibroblast phenotype,
by PTC, associated with disruption of the tubular basement
membrane in 5/6 nephrectomized rats [9]. Li et al. have also
demonstrated that advanced glycation end products and
induced epithelial-myofibroblast transdifferentiation in PTC
[10].
Transforming growth factor-beta-1 (TGF-b1), a prototypic
member of the TGF-b superfamily, exerts a broad range of
biological activities. It plays pivotal roles during embryonic
development where it is involved in induction of cell differ-
entiation and organogenesis. Furthermore, TGF-b1 has been
implicated in the pathogenesis of renal fibrosis in both
experimental and human disease [11e14]. In addition, TGF-b1
has been shown to be involved in oncogenesis as it can induce
EMT of mammary epithelial cells, thought to be important
during transformation of squamous carcinoma to invasive
spindle cell carcinoma [15,16]. In vitro studies also suggest that
TGF-b1-induced phenotypic alterations of PTC to form fibro-
blastoid morphology and a-SMA expression and loss of
epithelial markers, suggesting induction of EMT [17e19].
Early studies have demonstrated that tubular basement
membrane is an essential structure for maintenance of
epithelial phenotype as EMT of PTC is frequently associated
with damage of tubular basement membrane [9,20e22]. Zeis-
berg et al. have clearly shown that disruption of the structureof type IV collagen, a major component of basement mem-
brane, is essential for PTC transdifferentiation. These studies
would therefore suggest that although TGF-b1 is a critical
cytokine in the process of transdifferentiation, other factors
are likely to act in a cooperative way to complete the process.
Since type I collagen is the most abundant extracellular
matrix protein in the renal interstitium and the most possible
candidate that transdifferentiated PTC may frequently con-
tact with following migration through disrupted basement
membrane into the interstitium, the aim of this study was to
examine the combined effect of TGF-b1 stimulation and con-
tact with type I collagen on PTC phenotype and function. The
data demonstrate that contact with type I collagen have syn-
ergistic effects with TGF-b1, promoting irreversible PTC
transdifferentiation.Materials and methods
Cell culture
Human kidney-2 (HK2) cells (human renal PTC immortalized
by transduction with human papilloma virus 16 E6/E7 genes
[22]) were purchased from American Type Culture Collection
(Manassas, VA, USA). Cells were cultured in DMEM/Ham's F12
medium (Invitrogen Ltd.) supplemented with 10% fetal calf
serum (Biological Industries Ltd.), 2 mM glutamine (Life Tech-
nologies Ltd.), 20 mM HEPES buffer (Gibco BRL), 5 mg/mL in-
sulin, 5 mg/mL transferrin and 5 ng/mL sodium selenite
(Sigma). Cells were grown at 37 C in 5% CO2 and 95% air. Cells
were grown to confluence and then serum deprived for 48 h
prior to experimental manipulation. All experiments were
performed under serum free conditions. For cell culture plate
coated with type I collagen, 2 mg/mL of sterilized type I
collagen (Sigma)was added to tissue culture plate overnight to
form a monolayer of gel and cells were then seeded upon the
gel on the next day.
Immunocytochemistry
Immunocytochemistry was performed on cells grown in 8-
well chamber slides (Nunc, Gibco/BRL Life Technologies Ltd.)
[23]. Cells were grown to confluence and stimulated under
serum free conditions. Culture medium was subsequently
removed and the cell monolayer washed with sterile phos-
phate buffered saline (PBS). For immunostaining of cytoker-
atin, cells were fixed in acetone-methanol (1:1 vol/vol) for
20 min at 20 C. For the staining of a-SMA and E-cadherin,
cells were fixed in 3.5% paraformaldehyde for 15 min at room
temperature, and permeabilized with 0.1% triton in PBS for
5 min at room temperature. Following fixation, slides were
blocked with 5% Bovine serum albumin (BSA) for 1 h at room
temperature prior to a further washing step with PBS. Subse-
quently slides were incubated with the primary antibody
diluted in 1% BSA/PBS for 1 h at room temperature. Primary
antibodies included: Murine monoclonal anti-a-SMA clone
1A4 (Sigma), murine monoclonal anti-cytokeratin (DAKO),
and murine monoclonal anti-E-cadherin (Transduction Lab-
oratories). Following a further washing step slides were
incubated with the appropriate fluorescein isothiocyanate-
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 3 9e4 9 41conjugated secondary antibody. After washing with PBS, cells
were mounted with FluorSave™ reagent (Calbiochem) and
analyzed by confocal microscope (Leica TCS 4D).
Western blot analysis
Total cellular protein extraction was performed as described
previously [24]. Protein samples mixed with reducing sodium
dodecyl sulfate (SDS) sample buffer were resolved on a 10%
SDS-polyacrylamide gel electrophoresis and then electro-
blotted. Nonspecific binding was blocked with a 5% nonfat
milk solution. The membrane was then incubated with pri-
mary antibody overnight at 4 C followed by incubation with a
horseradish peroxidase-conjugated secondary antibody. Pro-
teins were visualized using enhanced chemiluminescence
(Amersham Bio-sciences, Amersham, UK).
Cell motility assay
Cell motility was assessed by migration assay using tissue
culture Transwell filters (Boyden chamber) [25]. Cells were
seeded onto the top of the Boyden chamber (8 mm pore) and
when confluent, cells were serum deprived prior to adding
stimuli to the lower chamber under serum free conditions. At
the end of the experimental period, filters of the Boyden
chamber were fixed with 3% paraformaldehyde with 1%
crystal violet in PBS. The upper surface of the filter was care-
fully wiped with a cotton-tipped applicator. Cells that passed
through the pores were counted in four random nonoverlap-
ping fields (20) and photographed with a Nikon microscope.
Zymography
In order to determine the effect of TGF-b1 on gelatinolytic
activity, confluent monolayers of cells were stimulated under
serum free conditions with recombinant TGF-b (10 ng/mL) forFig. 1 e Cooperative effect of transforming growth factor-beta-1 an
Human kidney-2 cells were grown on a plastic surface (AeC) or t
serum deprivation for 2 days. Cells were then incubated in the ab
beta-1 (10 ng/mL) (B, C, E and F) for 3 days. Subsequently, stability o
growth factor-beta-1 and addition of medium containing 10% fluor
Cell morphology was monitored and photographed by phase conup to 4 days. The conditionedmediumwas then collected and
subjected to zymography. Samples were run at 4 C on 7.5%
nonreducing SDS-polyacrylamide gels containing gelatin at a
final concentration of 1 mg/mL at 4 C. The gels were then
washed in 2.5% Triton at room temperature for 1 h prior to
incubation overnight at 37 C in 50 mM tris HCl pH 7.6 con-
taining 10mMCaCl2 and 0.05% Brij. The presence of gelatinase
activity was demonstrated by zones of lysis in the Coomassie
Blue stained gel [26].
Statistical analysis
All the data are presented as means ± standard error of the
mean. Statistical analysis was performed using the unpaired
Student's t-test. A value of p < 0.05 was considered to repre-
sent a significant difference.Results
Cooperative effects of TGF-b1 and contact with type I collagen
on alteration of cell phenotype.
Addition of recombinant TGF-b1 to growth arrested
monolayers of HK-2 cells led to a marked alteration in cell
morphology [Fig. 1B]. Three days after its addition cells lost
cellecell contact and become elongated, acquiring a fibro-
blastic phenotype. Terminal transdifferentiation implies
acquisition of a stable phenotype, removal of TGF-b1 and
addition of culture medium containing 10% fluorescence
correlation spectroscopy (FCS) for further 3 days resulted in
reversal of the TGF-b1 mediated alteration of cell phenotype
[Fig. 1C], such that the cells were indistinguishable from the
unstimulated cells [Fig. 1A].
To examine the effect of contact of cells with extracellular
matrix components, tissue culture flasks, or six well plates
were coated with type I collagen. Cells were seeded onto thed type I collagen substratum on alteration in cell phenotype.
ype I collagen substratum (DeF) to confluence followed by
sence (A and D) or presence of transforming growth factor-
f cell phenotype was determined by removal of transforming
escence correlation spectroscopy for further 3 days (C and F).
trast microscopy, 100.
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serum deprived for a further 48 h and cell phenotype moni-
tored by light microscopy either in the absence or presence of
recombinant TGF-b1 for 3 days. Cells grown on type I collagen
showed no gross change in cell phenotype [Fig. 1D] when
compared to that grown on the plastic [Fig. 1A]. Addition of
TGF-b1 to cells grown on type I collagen-coated dishes resul-
ted in a fibroblastoid morphologic change [Fig. 1E]. However,
unlike cells grown on the plastic, which returned to the
epithelial morphology following removal of TGF-b1, cells
grown on type I collagen substratum did not revert to the
epithelial phenotype upon withdrawal of TGF-b1 and addition
of normal medium [Fig. 1F].
Cooperative effects of TGF-b1 and contact with type I
collagen on alteration of phenotypic marker expression.
Acquisition of myofibroblastic markers was assessed using
immunocytochemical localization of a-SMA. Laser scanning
confocal microscopy, demonstrated very little staining in
control cells [Fig. 2A]. Up-regulation of a-SMA in fine reticular
pattern throughout the cell cytoplasm, was seen following
addition of recombinant TGF-b1 [Fig. 2B]. When cells were
grown on culture dishes coated with type I collagen, some
cells at the edge of cellmonolayer displayed a-SMA expression
[Fig. 2C]. Addition of TGF-b1 to cells seeded onto type IFig. 2 e Effect of transforming growth factor-beta-1 and contact w
muscle actin expression. Cells were grown on a plastic surface (A
(A and C) or presence (B and D) of transforming growth factor-be
Subsequently, cells were fixed with 3.5% paraformaldehyde and
immunocytochemistry and confocal microscopy as described incollagen-coated dishes led to a marked increase in the
expression of this myofibroblastic marker [Fig. 2D].
Both E-cadherin and cytokeratin were used as markers of
epithelial phenotype. In unstimulated growth arrested HK-2
cells, examination of fluorescence immunostaining for E-
cadherin under a confocal laser scanning microscope clearly
outlined cell contours [Fig. 3A]. The contour immunofluores-
cence of E-cadherin decreased and became discontinuous
either incubation with TGF-b1 [Fig. 3B]. Cells grown on type I
collagen substratum displayed some disruption of E-cadherin
expression although most outlined E-cadherin remained
intact [Fig. 3C]. Contrarily, simulation of cells seeded on type I
collagen coupled with TGF-b1 resulted in a remarkable loss of
E-cadherin immunostaining [Fig. 3D]. E-cadherin expression
was also examined by western blot analysis. Despite some
disruption of E-cadherin expression assessed by immunocy-
tochemistry in cells grown on type I collagen substratum, total
E-cadherin expression determined by western blot analysis
was not altered [Fig. 4A]. In agreement with results of immu-
nocytochemistry, stimulation with TGF-b1 and growth on a
collagen substratum led to a dramatic decrease of E-cadherin
expression [Fig. 4A]. As with alteration in cell morphology,
alteration in E-cadherin expression following addition of TGF-
b1 alone was reversible upon withdrawal of TGF-b1 and re-ith type I collagen on a myofibroblastic marker, a-smooth
and B) or type I collagen substratum (C and D) in the absence
ta-1 (10 ng/mL) under serum free condition for 3 days.
a-smooth muscle actin expression was assessed by
materials and methods, 400.
Fig. 3 e Effect of transforming growth factor-beta-1 and contact with type I collagen on an epithelial marker, E-cadherin
expression. Cells were grown on a plastic surface (A and B) or type I collagen substratum (C and D) in the absence (A and C) or
presence (B and D) of transforming growth factor-beta-1 (10 ng/mL) under serum free condition for 3 days. Subsequently, cells
were fixed with 3.5% paraformaldehyde and E-cadherin expression was assessed by immunocytochemistry and confocal
microscopy as described in materials and methods, 400.
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fourth lane vs. the second lane]. In contrast, the combination
of TGF-b1 together with growth on type I collagen led to down-
regulation of E-cadherin expression that was no affected by
withdrawal of TGF-b1 and re-introduction of normal 10% FCS
medium [Fig. 4B, the fifth lane vs. the third lane].
Synergistic effect of collagen and TGF-b1 were also seen on
cytokeratin expression [Fig. 5A]. Addition of TGF-b1 alone did
not lead to a decrease in cytokeratin expression [Fig. 5B],
suggesting that TGF-b1 alone is insufficient to cause complete
loss of epithelial markers. Contact with type I collagen resul-
ted in a relative decrease in the expression of cytokeratin
[Fig. 5C], while obvious loss of cytokeratin expressionwas only
seen when both TGF-b1 and the type I collagen substratum
were applied [Fig. 5D]. This result suggests that TGF-b1 and
contact with type I collagen can induce more complete
transdifferentiation.
Cooperative effect of TGF-b1 and contact with type I
collagen on alteration of extracellular matrix protein
production.
Type III and IV collagen expression in cell culture super-
natant was examined to determine if alteration in cell
phenotype was associated with alteration in the generation ofextracellularmatrix. Stimulationwith TGF-b1, led to amarked
increase in the generation of type IV collagen [Fig. 6A]. Contact
with type I collagen had little effect of type IV collagen gen-
eration, while addition of TGF-b1 and concurrent contact with
type I collagen had no greater effect on type IV collagen gen-
eration than addition of TGF-b1 alone. In contrast, stimulation
with either TGF-b1, or contact with type I collagen led to
stimulation of type III collagen [Fig. 6B]. The combination of
TGF-b1 and a type I substratum led to a synergistic increase in
type III collagen in the cell culture supernatant. There was no
cross-reactivity of the antibody used for detection of type III
collagen, with the type I collagen used in these experiments.
These results therefore suggest that transformation of
epithelial cells is associated with an alteration in the ratio of
type III to type IV collagen synthesis.
Cooperative effect of TGF-b1 and contact with type I
collagen on enhancement of cell migration. In order to un-
derstand how TGF-b1 influences PTC migration and hence
their potential entry into the interstitial compartment, we
utilized a Transwell migration assay by counting the number
of cells migrating through the Boyden chamber. In control
experiments, in which cells were bathed in serum free culture
medium in both upper and lower chambers, very few cells
Fig. 5 e Effect of transforming growth factor-beta and contact wi
expression. Cells were grown on a plastic surface (A and B) or typ
presence (B and D) of transforming growth factor-beta-1 (10 ng/m
were fixed with acetone-methanol (1:1) and cytokeratin expressio
microscopy as described in Materials and methods, 400.
Fig. 4 e Regulation of E-cadherin expression by transforming
growth factor-beta-1 and contact with type I collagen. (A)
Cells seeded on a plastic surface or type I collagen substratum
were serum deprived for 2 days and then incubated in the
absence or presence of transforming growth factor-beta-1
(10 ng/mL) under serum free condition for further 3 days. (B)
To examine the reversibility of E-cadherin expression, culture
medium containing transforming growth factor-beta was
removed and replaced by normal culturemedium containing
10% fluorescence correlation spectroscopy for 3 days. At the
end of each experiment, cells were lysed and subjected to
western blot analysis for E-cadherin expression described in
methodologies.
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shown in Fig. 7, addition of TGF-b1 to the lower chamber led
marked increase in cell migration manifested as a 4-fold in-
crease in the number of cells migrating through the Boyden
chamber (5.1 ± 0.3 vs. 21.9 ± 2.1, n ¼ 8, p < 0.001). Addition of
type I collagen to the lower chamber also increased cell
number migrating through the chamber (5.1 ± 0.3 vs.
21.8 ± 3.8, n ¼ 8, p < 0.001). Addition of both TGF-b1 and type I
collagen to the lower chamber led to a synergistic enhance-
ment in cell migration with an 11-fold increase in cell number
as compared to the control (5.1 ± 0.3 vs. 55.5 ± 4.9, n ¼ 8,
p < 0.001).
To assess if the migrated cells expressed myofibroblastic
characteristics, cells were grown on the filter of the Boyden
chamber and stimulated with the combination of TGF-b1 and
type I collagen added to the lower chamber for 2 days.
Immunofluorescent staining demonstrated that the cells
migrating through the Boyden chamber displayed a strong a-
SMA expression [Fig. 8B] and a decrease of cytokeratin
expression [Fig. 8D] when compared to unstimulated cells on
the upper chamber [Fig. 8A and C]. This finding clearly indi-
cated that the cells with increased migration capacity became
myofibroblastoid and lost their epithelial characteristics.
One important aspect of this work is how PTC could come
into contact with interstitial collagen. Since matrix metal-
loproteinases (MMPs) are major enzymes for extracellular
matrix degradation to allow PTC to contact the interstitium,
we examined the effect of TGF-b1 on matrix degradation byth type I collagen on another epithelial marker, cytokeratin
e I collagen substratum (C and D) in the absence (A and C) or
L) under serum free condition for 3 days. Subsequently, cells
n was assessed by immunocytochemistry and confocal
Fig. 6 e Type IV or III collagen protein expression in the cell
supernatant following stimulation. Confluent monolayers of
human kidney-2 cells were stimulated with recombinant
transforming growth factor-beta-1 (10 ng/mL) under serum
free conditions either in cells grown on tissue culture plastic,
or cells grown on a type I collagen substratum for 3 days.
Subsequently, the culture supernatant was subjected to
western blot analysis to measure type IV collagen (A) or type
III collagen (B) production.
Fig. 7 e Migration of proximal tubular epithelial cells by
different stimulations. Human kidney-2 cells were seeded
on the filters of the Boyden chamber (pore size 8 mm).
Confluent serum deprived cells were stimulated with
transforming growth factor-beta-1 (10 ng/mL) (transforming
growth factor), type I collagen (500 mg/mL) (Col I) or the
combination of both stimuli (Col I þ transforming growth
factor) added to the lower chamber for further 2 days. In
control experiments serum free medium only was added to
the lower chamber (control). In all experiment serum free
medium alone was added to the upper chamber. At the end
of the experiment, filters were fixed with 3%
paraformaldehyde with 1% crystal violet in phosphate
buffered saline. The upper surface of the filter was carefully
wiped with a cotton-tipped applicator and the number of
cells migrating through the pore onto the bottom surface of
the filter was calculated. Data represents mean ± standard
error, n ¼ 8 *p < 0.001 compared to both control value or in
the case of combination, compared to either stimulus alone.
**p < 0.01 compared to control.
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of MMP9 activity following addition of TGF-b1 was apparent at
day 2 [Fig. 9A]. There was also a dose-dependent relationship
with the concentration of TGF-b1 added [Fig. 9B].Discussion
With increasing awareness of the mechanisms of renal
fibrosis, PTC, which make up the bulk of the tubulointer-
stitium, have been demonstrated to play a pro-fibrotic role in
the development of tubulointerstitial fibrosis in numerous
ways. PTC react to proteinuria by generation of chemokines
which initiate interstitial inflammatory infiltrates [27e29]. In
addition they may alter extracellular matrix turnover
[26,30,31] and generate pro-fibrotic cytokines such as TGF-b1
[12,32e34]. In recent years, increasing evidence demonstrates
that PTC can contribute to tubulointerstitial fibrosis through
EMT induced by different stimuli such as advanced glycated
end products and TGF-b1 to transdifferentiate into myofibro-
blasts [10,17,35].
TGF-b1 is one of the most important cytokines involved in
EMT in many different tissues [36,37]. The process of EMT
involves loss of epithelial phenotype, de novo expression of a-
smooth muscle actin and actin reorganization, disruption of
the tubular basement membrane and enhanced migration
and invasive capacity of the transformed cells. Although
addition of TGF-b1 is a known modulator or PTC phenotype
and function [35], numerous studies have demonstrated that
TGF-b1 together with other cytokines such as epidermal
growth factor (EGF) [38], or fibroblast growth factor [39] are
required to optimally affect EMT at least in vitro.
Studies by Zeisberg et al. using a murine cell line have
demonstrated that integrity of basement membrane collagen
has a significant effect on EMT in vitro. Their studies demon-
strate that type IV collagen, a major component of the tubular
basement membrane, contributes to the maintenance of the
epithelial phenotype of PTC, whereas inhibition of type IV
collagen assembly stimulates the production of TGF-b1 thus
facilitating phenotypic change [40]. Ng et al. have shown in
tubulointerstitial fibrosis of the nephrectomized rats that PTC
expressing a-SMA are associated with disruption of the
tubular basement membrane Furthermore, Humphreys et al.
have also demonstrated a failure of tubular epithelial cells to
undergo EMT following kidney injury if PTC are confined with
the tubular basementmembrane [3]. These results suggest the
importance of the contact with the interstitial components in
the induction of EMT. Since type I collagen is the most abun-
dant interstitial matrix in the tubulointerstitium of renal
fibrosis and provided by evidence that TGF-b1 is a major
culprit of renal fibrosis, we hypothesized that the concurrent
stimulation with TGF-b1 and contact with type I collagen may
facilitate transdifferentiation of PTC into myofibroblasts. In
line with our previous work [31,35,41], the results of this study
demonstrated that stimulation with TGF-b1 caused a pheno-
typic change from epithelial morphology to a fibroblastic
morphology and also resulted in a decrease in the expression
of E-cadherin, an epithelial marker, and an increase in the
expression of a-SMA, a myofibroblast marker. Interestingly,
stimulation of TGF-b1 alone did not reduce the expression of
Fig. 8 e The expression of a-smooth muscle actin and cytokeratin in migrated cells. Cells were seeded on the transwell filters
(Boyden chamber) and serum deprived for 2 days. Subsequently, cells were stimulated with the combination of transforming
growth factor-beta-1 (10 ng/mL) and type I collagen (500 mg/mL) added to the lower chamber for further 2 days. The cells were
then fixed with 3% paraformaldehyde and the upper surface of the filter was carefully wiped with a cotton-tipped applicator.
The cells migrating through the chamber were immunostained with a-smooth muscle actin (B) or cytokeratin (D). In the
control, cells were grown only in the serum free medium for 2 days. The cells on the lower surface of the filter were removed
and those remained on the upper surface were immunostained with a-smooth muscle actin (A) or cytokeratin (D), (A and B:
200, B and D, 400.
Fig. 9 e Stimulation of matrix metalloproteinases-9 activity
following addition of transforming growth factor-beta-1.
Confluent monolayers of cells were stimulated with
recombinant transforming growth factor-beta (10 ng/mL) for
up to 4 days (A) or increasing doses (0, 10, 50 ng/mL) for 4
days (B). Supernatant samples were collected and gelatinase
activity assessed by substrate zymography as described in
Materials and methods.
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transdifferentiation of PTC under stimulation of TGF-b1 alone.
In contrast, while contact with type I collagen alone did not
cause a significantly morphological change or reduce the
expression of E-cadherin and cytokeratin or acquest the
expression of a-SMA, concurrent stimulation of TGF-b1 and
contact with type I collagen led to a more significant decrease
in the E-cadherin expression and a more prominent increase
in the a-SMA expression, and the most importantly, a
decrease in the cytokeratin expression, suggesting more
complete transdifferentiation. Interestingly, Okada et al. have
demonstrated that growth of murine PTC on a type I collagen
substratum also led to transdifferentiation as assessed by the
expression of FSP1, a fibroblast-specific protein associated
with mesenchymal cell morphology [38]. Our work using PTC
would confirm the hypothesis that contact with type I
collagenwould facilitate TGF-b1-induced transdifferentiation.
Transdifferentiation of epithelial cells to fibroblastic cells is
generally accompanied by a change in the extracellularmatrix
synthetic profile from basement membrane to interstitial
components reflected by alterations in type III to IV collagen
synthesis ratios [38]. In this study, we also examined collagen
generation as a further measure of change in functionality. As
with all other parameters used to examine epithelial-
mesenchymal transdifferentiation, although TGF-b1 alone
increased type III collagen synthesis, the effect on type III
collagen synthesis was far greater when both stimuli were
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 3 9e4 9 47applied together, suggesting more complete trans-
differentiation in cell function.
Once PTC transdifferentiate into myofibroblasts and move
into the interstitium, in theory, they cannot rapidly undergo
reverse phenotypic change from myofibroblasts back to PTC.
In this study, following removal of TGF-b1 for 72 h, TGF-b1-
stimulated transformed PTC promptly regained their epithe-
lial morphology. In contrast, transdifferentiated PTC induced
by concurrent stimulation of TGF-b1 and contact with type I
collagen remained their fibroblastic morphology even if TGF-
b1 was removed. We speculate that transdifferentiated PTC
once move into the interstitium and are then stuck in micro-
environment full of type I collagen, causing an irreversible
phenotypic alteration.
In addition to phenotypic and functional alterations,
transdifferentiated PTC need to move into the interstitial
compartment if they are to function as myofibroblasts. Our
results using a Transwell system demonstrate that PTC
respond to chemotactic stimulation by TGF-b1. Furthermore,
the chemotactic effect of TGF-b1 was augmented by the
presence of type I collagen in the lower chamber. This would
suggest that exposure of PTC on their basolateral aspect to
type I collagen facilitates migration, and is in agreement with
our previous studies demonstrating that TGF-b1mediated loss
of cellecell contact and disassembly of adherens junctions
were seen following addition of TGF-b1 to the basolateral
aspect of the cells [41].
As Zeisberg et al. and Ng et al. have emphasized the
importance of an intact tubular basement membrane in
preservation of an epithelial phenotype during the process of
transdifferentiation [9,40], how might alterations in organi-
zation and composition of the basement membrane be
mediated? MMPs have been demonstrated to be implicated in
renal fibrosis [30,42,43]. Addition of TGF-b1 in our experi-
mental system led to both a time and dose-dependent in-
duction of MMP-9 in PTC. This suggests that TGF-b1 may be
involved in basement membrane disruption to allow PTC to
contact with the interstitial components. Further support for
the importance of the interaction between TGF-b1 and MMP
comes from a study demonstrating thatMMP9 can trigger EMT
inmurine PTC and TGF-b1-induced EMT is blocked by MMP2/9
inhibitors [44]. In addition, Cheng et al. also show that gelati-
nase A (MMP2) were co-localized to sites of active epithelial-
mesenchymal transformation and basal lamina disruption,
suggesting a possibility that MMP causes complex rearrange-
ment of microenvironment in EMT [30]. We have previously
demonstrated that MMP2/9 inhibitors abrogated EGF and TGF-
b1-co-stimulated EMT and cell migration, further verifying the
importance of MMPs in EMT [31]. Nevertheless, whether other
factors that can disrupt the integrity of basement membrane
structure also facilitate EMT formation requires further
investigation.
The mechanism beyond the synergistic effect of contact
with type I collagen and TGF-b1 stimulation remains unclear.
We have previously demonstrated that TGF-b1 and EGF can
synergistically induce PTC transdifferentiation through sus-
tained activation of extracellular signal-regulated kinase (ERK)
signals [31]. As contact with type I collagen also induces
activation of ERK signals [45e47], it is tempting to speculate
that combination of TGF-b1 stimulation and contact with typeI collagen cooperatively causes sustained activation of the ERK
cascade to maintain complete transdifferentiation. In vitro
studies have reported in some cell types that grown on type I
collagen gel leads to an invasive morphological change
accompanied by increased expression of some mesenchymal
markers and loss of epithelialmarkers. In this study, grown on
type I collagen substratum alone also caused an increase in a-
SMA expression and migratory cell number. However, unlike
TGF-b1, it did not enhance type IV collagen synthesis or
reduce E-cadherin expression determined western blot anal-
ysis despite some disruption of E-cadherin assessed by im-
munostaining. We speculate that activation of some specific
pathways in contact with type I collagen or TGF-b1 stimula-
tion may be attributed to the discrepancy in these two
different reactions. For example, the classical Smad pathway
specifically induced by TGF-b1 but not by contact with type I
collagen (our observation) may bring about different
responses.
In summary, the current study has demonstrated induction
of a stable transformed phenotype of proximal tubular epithe-
lial cells in which all of parameters indicative of a fibroblastic
transformation may be regulated in a cooperative manner by
the pro-fibrotic cytokine TGF-b1 and exposure of PTC to an
interstitial extracellular matrix component, type I collagen.Source of support
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